chr9-35740225-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000378103.7(GBA2):c.1267G>A(p.Gly423Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0024 in 1,614,110 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G423G) has been classified as Likely benign.
Frequency
Consequence
ENST00000378103.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBA2 | NM_020944.3 | c.1267G>A | p.Gly423Ser | missense_variant | 7/17 | ENST00000378103.7 | NP_065995.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBA2 | ENST00000378103.7 | c.1267G>A | p.Gly423Ser | missense_variant | 7/17 | 1 | NM_020944.3 | ENSP00000367343 | P1 | |
GBA2 | ENST00000378094.4 | c.1267G>A | p.Gly423Ser | missense_variant | 7/17 | 1 | ENSP00000367334 | |||
GBA2 | ENST00000467252.5 | n.839G>A | non_coding_transcript_exon_variant | 4/13 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0131 AC: 1994AN: 152136Hom.: 44 Cov.: 32
GnomAD3 exomes AF: 0.00343 AC: 861AN: 251230Hom.: 23 AF XY: 0.00243 AC XY: 330AN XY: 135818
GnomAD4 exome AF: 0.00129 AC: 1885AN: 1461856Hom.: 35 Cov.: 32 AF XY: 0.00111 AC XY: 809AN XY: 727234
GnomAD4 genome AF: 0.0131 AC: 1991AN: 152254Hom.: 44 Cov.: 32 AF XY: 0.0125 AC XY: 932AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jul 26, 2017 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 01, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Hereditary spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Jun 16, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at